← Open Payments lookup

AMA GYIMAH: Open Payments

NPI 1295597136 · MERIDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,267 in 94 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,339 · 2025 $3,267

Food & beverage: $3,156Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$594
Alkermes, Inc.15$448
E.R. Squibb & Sons, L.L.C.14$441
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$373
ABBVIE INC.12$362
Otsuka America Pharmaceutical, Inc.7$277
Neurocrine BioSciences, Inc.6$240
Janssen Pharmaceuticals, Inc6$203
Luye Pharma (USA) Ltd.4$191
Indivior Inc.2$57

Products named: COBENFY, UZEDY, CAPLYTA, VRAYLAR, INGREZZA, ARISTADA, ERZOFRI EXTENDED-RELEASE, SPRAVATO.

Industry payments across CT — which companies pay providers there.